Becton Dickinson pledges $19 billion US investment in deal with government
BDX•Becton Dickinson pledged $19 billion in US capital, operational and supply chain investments over several years in return for relief from future tariffs on covered products and inputs. The plan includes $3 billion for manufacturing sites and aims to add about 5 billion annual medical consumables, raising its domestic supply share to roughly 80%.
1. Investment and tariff relief
Becton Dickinson said it plans to invest $19 billion in the United States over several years under an agreement tying its manufacturing commitments to relief from future tariffs on covered products and inputs under Section 232. The relief is subject to the final scope of the measures and the company meeting agreed milestones. The plan earmarks $3 billion for manufacturing sites across the country.
2. Domestic production plans
The company aims to expand US production by about 5 billion essential medical consumables annually, raising the share it supplies domestically to roughly 80%. It also plans to manufacture all needles used in the United States domestically using American-made steel.
3. Financial impact undetermined
Becton Dickinson said it is not currently quantifying the agreement's financial impact because final tariff rates, product scope and timing have not been determined. The announcement builds on President Donald Trump's statement that the company had agreed to invest $3 billion to bring essential medical products manufacturing to the United States, with more than $1 billion going to Nebraska.
